Location History:
- Parkville, AU (2001)
- Port Melbourne, AU (2002)
Company Filing History:
Years Active: 2001-2002
Introduction
Kevin George Whithear is a prominent inventor based in Port Melbourne, Australia. With a focus on advancements in biological sciences, he has made significant contributions to the fields of immunology and pathogen identification through his innovative inventions.
Latest Patents
Kevin holds two notable patents. The first one details a PCR-based method for the identification of Eimeria species and strains, commonly known as coccidia. This genus-specific method utilizes two novel primer sets—WW1 and WW3r, and WW2 and WW4r—which enhance the accurate identification of these pathogens.
His second patent revolves around Mycoplasma recombinant polypeptides and vaccines. This invention is centered on the development of immunogens that are crucial in vaccine preparations. The immunogens are designed to mimic or cross-react with B-cell or T-cell epitopes on surface polypeptides encoded by Mycoplasma species. Additionally, this invention provides diagnostic reagents for detecting Mycoplasma in biological samples.
Career Highlights
Kevin works at the University of Melbourne, where he contributes to research and development in the biomedical field. His work has been instrumental in advancing the understanding of infectious diseases and vaccine development.
Collaborations
Throughout his career, Kevin has collaborated with esteemed colleagues such as Robin Beat Gasser and Wayne Geoffrey Woods. These collaborations have fostered a dynamic research environment, promoting innovation and the sharing of knowledge.
Conclusion
Kevin George Whithear’s contributions to innovation in immunology and pathogen identification render him a valuable asset in the scientific community. His patents not only reflect his expertise but also underline his commitment to advancing medical science for better health outcomes.